Agata Wrzesień‐Kuś

Cladribine combined with high doses of arabinoside cytosine, mitoxantrone, and G‐CSF (CLAG‐M) is a highly effective salvage regimen in patients with refractory and relapsed acute myeloid leukemia of the poor risk: a final report of the Polish Adult Leukemia Group

Agnieszka Wierzbowska, Tadeusz Robak, Agnieszka Pluta et al. · European Journal Of Haematology · 2007 · 142 citations · Full text

Combination Regimen of Cladribine (2-Chlorodeoxyadenosine), Cytarabine and G-CSF (CLAG) as Induction Therapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia

Tadeusz Robak, Agata Wrzesień‐Kuś, Ewa Lech‐Marańda et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2000 · 66 citations

Hematological Malignancy, Oncology, Induction Therapy +13

Circulating endothelial cells in patients with acute myeloid leukemia

Agnieszka Wierzbowska, Tadeusz Robak, Anna Krawczyńska et al. · European Journal Of Haematology · 2005 · 64 citations

A multicenter, open, non‐comparative, phase II study of the combination of cladribine (2‐chlorodeoxyadenosine), cytarabine, and G‐CSF as induction therapy in refractory acute myeloid leukemia – a report of the Polish Adult Leukemia Group (PALG)

Agata Wrzesień‐Kuś, Tadeusz Robak, Ewa Lech‐Marańda et al. · European Journal Of Haematology · 2003 · 61 citations

The influence of palifermin (Kepivance) on oral mucositis and acute graft versus host disease in patients with hematological diseases undergoing hematopoietic stem cell transplant

Barbara Nasiłowska‐Adamska, Piotr Rzepecki, Joanna Mańko et al. · Bone Marrow Transplantation · 2007 · 56 citations · Full text

Inflammation, Cell Therapy, Transplantation +10